Litigation

Recent Posts

FTC Rules Get E-Discovery Makeover This Month
Posted on 6 Nov 2012 by LexisNexis Litigation Resource Community Staff

When really broad neckties went out of style, one solution might have been to take a pair of scissors to them and snip them to a modern-day width. Smarter guys might simply have taken them to a tailor. Others might have made them into kites. But most... Read More

Berman DeValerio Files Class Action Lawsuit Extending Class Period In BP Action
Posted on 23 Jul 2010 by LexisNexis Litigation Resource Community Staff

NEW ORLEANS, La. - The law firm of Berman DeValerio has filed a securities fraud lawsuit against BP plc, expanding the complaint to cover certain investors who acquired BP stock as early as mid-2005 ( The Oklahoma Police Pension & Retirement System... Read More

C.R. Bard Takes $51 Million Charge, Agrees To Settle Federal Civil, Criminal Probes
Posted on 27 Jan 2012 by Tom Moylan

MURRAY HILL, N.J. - (Mealey's) C.R. Bard Inc. on Jan. 27 reported that it has taken a $51 million charge in connection with a preliminary agreement with the civil and criminal divisions of the U.S. Attorney's Office for the Northern District of... Read More

GSK To Pay $229 Million To Settle Avandia, Drug Lawsuits By 8 State Attorneys General
Posted on 26 Jul 2013 by Tom Moylan

LONDON — (Mealey's) GlaxoSmithKline plc (GSK) on July 24 said it has reached an agreement in principle with the attorneys general of seven states to pay $229 million to resolve lawsuits relating to the development and marketing of the diabetes... Read More

Teva Settles 'Vast Majority' Of Propofol Vial/Hepatitis C Infection Cases In Nevada
Posted on 21 Feb 2012 by Tom Moylan

NORTH WALES, Pa. - (Mealey's) Teva Pharmaceuticals Industries Ltd. has agreed to settle "the vast majority" of its propofol vial/hepatitis C cases, a company spokesperson said Feb. 21. Teva did not disclose the amount of the settlement... Read More

$2.36B Glaxo Charge Covers Avandia, Paxil Litigation, Other Legal Costs
Posted on 15 Jul 2010 by Tom Moylan

LONDON - (Mealey's) GlaxoSmithKline PLC (GSK) on July 15 said it expects to take a $2.36 billion charge against earnings to settle several legal issues, including settling "the substantial majority" of Avandia product liability cases and... Read More

Goldman Sachs To Pay $550M To Settle Charges It Misled Subprime Investors
Posted on 16 Jul 2010 by Dylan McGuire

NEW YORK - Goldman, Sachs & Co. has agreed to pay $550 million in penalties and to change its business practices to settle allegations brought by the U.S. Securities and Exchange Commission that it misled investors in a subprime mortgage product,... Read More